维普中文期刊产品整合服务
17篇 您的检索式:作者名="Takiuchi I"
    题名 作者 年代 出处 被引量
1Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial:ACTS-CC trial显示文摘Mochizuki I Takiuchi H Ikejiri K 2012Br J Cancer2012,106,7:1
2Safety of UFT/ LV and S-1 as adjuvant therapy for stage III colon can- cer in phase III trial: ACTS-CC trial显示文摘Mochizuki I Takiuchi H Ikejiri K 2012Br J Cancer2012,106,7:1
3Treatment outcome and relapse with short-term oral terbinafine(250 mg/day)in tinea pedis显示文摘Takiuchi I Morishita N Hamaguchi T 2005Nihon Ishinkin Gakkai Zasshi2005,46,4:1
4Treatment outcome and relapse with short-term oral terbinafine (250 mg/day) in tinea pedis显示文摘Takiuchi I Morishita N Hamaguchi T 2005Nippon Ishinkin Gakkai Zasshi2005,46,4:1
5Immunohistochmical expression of vascular endothelial growth factor can predict response to 5-fluorouracil and cisplatin in patients with gastric adenocarcinoma显示文摘Takiuchi H Hirata I Kawabe S 2000Oncol Rep2000,7,4:1
6Treatment outcome and relapse with short-term oral terbinafine (250 mg/day) in tinea pedis显示文摘Takiuchi I Morishita N Hamaguchi T 2005Nippon Ishinkin Gakkai Zasshi2005,46,4:1
7Treatment outcome and relapse with short-term oral terbinafine(250 ms/day)in tinea pedis显示文摘Takiuchi I Morishita N Hamaguchi T 2005Nippon Ishinkin Gakkai Zasshi2005,46,4:1
8Treatment outcome and relapse with short-term oral terbinafine( 250 mg,/day) in tin- ea pedis显示文摘Takiuchi I Morishita N Hamaguchi T 2005Nippon Ishinkin Gakkai Zasshi2005,46,4:1
9Treatment outcome and relapse with short-term oral terbinafine (250 mg/day) in tinea pedis显示文摘Takiuchi I Morishita N Hamaguchi T 2005Nippon Ishinkin Gakkai Zasshi2005,46,4:1
10Immunohistochemical expression of vascular endothelial growth factor can predict respone to 5-fluorouracil and cisplatin in patients with gastric adenocarcinoma显示文摘Takiuchi H Hirata I Kawabe S 2000Oncol Rep2000,7,4:1
11Immunohistochemical expression of vascular endothelial growth factor can predict response to 5-fluorouracil and cisplatin in patients with gastric adenocarcinoma显示文摘Takiuchi H Hirata I Kawabe S 2000Oncol Rep2000,7,4:1
12Treatment outcome and relapse with short-term oral terbinafine(250 mg/day)in tinea pedis显示文摘Takiuchi I Morishita N Hamaguchi T 2005Nippon Ishinkin Gakkai Zasshi2005,46,4:1
13Treatment outcome and relapse with short-term oral terbinafine (250 mg/day) in tinea pedis显示文摘Takiuchi I Morishita N Hamaguchi T 2005Nihon Ishinkin Gakkai Zasshi2005,46,4:1
14Treatment outcome and relapse with short-term oral terbinafine(250mg/day) in tine- a pedis显示文摘Takiuchi I Morishita N I-lamaguchi T 2008Nippon Ishinkin Gakkai Zasshi2008,49,4:1
15Treatment outcome and relapse with short-term oral terbinafifie f 250 mg /day 1 in tineapedis显示文摘Takiuchi I Morishita N Hamaguchi T 2005Nippon Ishinkin Gakkai Zasshi2005,46,4:1
16显示文摘Takiuchi H Hirata I Kawabe S 2000Oncol Rep2000,7,4:1
17Immunohistochemical expression of vascular endothelial growth factor can predict response to 5 - fluorouracil and cisplatin in patients with gastric adenocarcinoma 显示文摘Takiuchi H Hirata I Kawabe S 2000Oncol Rep2000,7,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费